Evolving Dynamics in the HER2-Low Cancer Landscape: Market Outlook...

ha aggiunto una foto Health

2025-09-13 15:51:28

Evolving Dynamics in the HER2-Low Cancer Landscape: Market Outlook and Growth Potential

Introduction The recognition of the “HER2-low” subgroup has significantly changed how clinicians and researchers view HER2 biology. Once categorized under HER2-negative disease, HER2-low tumors — typically defined as IHC 1+ or IHC 2+/ISH– — are now seen as actionable, particularly in breast cancer, following the breakthrough of antibody–drug conjugates...

0 Commenti 0 condivisioni 95 Views 0 Anteprima